Latest News

Last week, researchers in Iceland announced the completion of a large project to sequence the genomes (or complete DNA) of 2,636 of their fellow countrymen. The Icelandic data base is being called a “treasure trove” of information that will further scientists’ understanding of diseases that are not caused by one single genetic mutation, but instead to mutations on several different genes.

Good news from Yale—researchers there report early success using a still-experimental cancer drug known as saracatinib to treat Alzheimer’s disease in mice.

Maddy Dychtwald, a renowned expert on our nation's changing demographic trends and aging, has joined the BrightFocus Foundation’s Board of Directors.

In two studies receiving international attention, 2013-16 BrightFocus grantee Rik Ossenkoppele, PhD, of Vrije Universiteit (VU) Medical Center, Amsterdam, and colleagues in the Netherlands have lent confidence to our understanding of how Alzheimer’s develops. Their findings help confirm that amyloid beta (Aβ) peptide levels start to build up and aggregate long before Alzheimer’s symptoms develop, and are predictive of disease.

The BrightFocus Foundation today honored seven outstanding scientists in the fields of macular degeneration and glaucoma, awarding them research grants named in honor of leaders in vision research and advocacy.

Gordon Legge of the University of Minnesota and Robert Massof of the Johns Hopkins Wilmer Eye Institute will today receive the prestigious 2015 Helen Keller Prize for Vision Research. The award is jointly presented by the Helen Keller Foundation for Research and Education and BrightFocus Foundation.

The Helen Keller Foundation for Research and Education and BrightFocus Foundation today announced that they will jointly present the prestigious Helen Keller Prize for Vision Research.

BrightFocus Foundation today announced $11 million in new research grant awards, a record amount for the non-profit in its efforts to cure diseases of mind and sight.

Targeting the growing rates of glaucoma and macular degeneration, the BrightFocus Foundation today launched a new Public Service Announcement (PSA) campaign, “Make a Plan Today: Get Your Eyes Checked.”

Being diagnosed with Alzheimer’s disease can be overwhelming, but the BrightFocus Foundation wants to help people take an active, informed role in their health care. In recognition of November’s Alzheimer’s Awareness Month, BrightFocus is offering a free, pocket-sized card of questions—available in English and Spanish—to bring to the doctor’s office.